Cargando…
Guanidinoacetate–creatine in secondary progressive multiple sclerosis: a case report
Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options. A 48-year-old woman with acute SPMS being treated with interferon beta-1a and oral corticosteroids presented as a clinical outpatient with...
Autores principales: | Ostojic, Sergej M., Ostojic, Jelena, Zanini, Dragana, Jezdimirovic, Tatjana, Stajer, Valdemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753084/ https://www.ncbi.nlm.nih.gov/pubmed/35000485 http://dx.doi.org/10.1177/03000605211073305 |
Ejemplares similares
-
Searching for a better formulation to enhance muscle bioenergetics: A randomized controlled trial of creatine nitrate plus creatinine vs. creatine nitrate vs. creatine monohydrate in healthy men
por: Ostojic, Sergej M., et al.
Publicado: (2019) -
Guanidinoacetic acid in human nutrition: Beyond creatine synthesis
por: Ostojic, Sergej M., et al.
Publicado: (2023) -
Effects of six‐month creatine supplementation on patient‐ and clinician‐reported outcomes, and tissue creatine levels in patients with post‐COVID‐19 fatigue syndrome
por: Slankamenac, Jelena, et al.
Publicado: (2023) -
Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy
por: Ostojic, Sergej M.
Publicado: (2022) -
Hydrogen‐rich water and caffeine for alertness and brain metabolism in sleep‐deprived habitual coffee drinkers
por: Todorovic, Nikola, et al.
Publicado: (2021)